We are live on ! Find out more
Walleye Capital

Walleye Capital Portfolio holdings

AUM $24B
1-Year Est. Return 37.67%
This Fund
S&P 500
This Quarter Est. Return
+4.23%
1 Year Est. Return
+37.67%
3 Year Est. Return
+98.01%
5 Year Est. Return
+160%
10 Year Est. Return
AUM
$910M
AUM Growth
+$303M
Cap. Flow
+$298M
Cap. Flow %
32.79%
Top 10 Hldgs %
6.34%
Holding
2,256
New
789
Increased
455
Reduced
377
Closed
581
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GXGXU
51
DELISTED
GX Acquisiton Corp. Unit
GXGXU
$2.63M 0.29%
+261,600
New +$2.63M
EW icon
52
CALL
Edwards Lifesciences
EW
$47.6B
$2.62M 0.29%
42,600
+35,400
+492% +$2.14M
AIG icon
53
CALL
American International
AIG
$41.9B
$2.62M 0.29%
49,200
+14,300
+41% +$712K
CRL icon
54
CALL
Charles River Laboratories
CRL
$10.9B
$2.61M 0.29%
18,400
+7,800
+74% +$1.06M
EXAS
55
CALL
DELISTED
Exact Sciences
EXAS
$2.61M 0.29%
22,100
+4,900
+28% +$494K
ORCL icon
56
CALL
Oracle
ORCL
$331B
$2.6M 0.29%
45,700
-7,800
-15% -$422K
GWPH
57
CALL
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$2.6M 0.29%
15,100
+5,100
+51% +$882K
KSS icon
58
CALL
Kohl's
KSS
$2.03B
$2.59M 0.28%
54,500
+45,900
+534% +$2.77M
MDT icon
59
CALL
Medtronic
MDT
$107B
$2.59M 0.28%
26,600
+11,800
+80% +$1.08M
META icon
60
CALL
Meta Platforms (Facebook)
META
$1.51T
$2.55M 0.28%
13,200
-600
-4% -$110K
ZS icon
61
CALL
Zscaler
ZS
$23B
$2.52M 0.28%
32,900
+12,600
+62% +$898K
BR icon
62
CALL
Broadridge
BR
$17.2B
$2.52M 0.28%
19,700
+13,600
+223% +$1.64M
CCL icon
63
CALL
Carnival Corporation Ltd
CCL
$36.1B
$2.51M 0.28%
53,900
+36,100
+203% +$1.89M
BIO icon
64
CALL
Bio-Rad Laboratories Class A
BIO
$8.42B
$2.5M 0.27%
+8,000
New +$2.4M
PLNT icon
65
CALL
Planet Fitness
PLNT
$4.23B
$2.49M 0.27%
+34,400
New +$2.59M
INCY icon
66
CALL
Incyte
INCY
$23.5B
$2.44M 0.27%
28,700
+22,100
+335% +$1.77M
W icon
67
CALL
Wayfair
W
$11.1B
$2.42M 0.27%
16,600
+14,200
+592% +$2.14M
NVDA icon
68
CALL
NVIDIA
NVDA
$5.01T
$2.38M 0.26%
+580,000
New +$2.4M
HAS icon
69
CALL
Hasbro
HAS
$12.6B
$2.37M 0.26%
22,400
+19,700
+730% +$1.94M
CBM
70
CALL
DELISTED
Cambrex Corporation
CBM
$2.34M 0.26%
49,900
+35,700
+251% +$1.5M
LCAHU
71
DELISTED
Landcadia Holdings II, Inc. Unit
LCAHU
$2.3M 0.25%
+229,700
New +$2.3M
FITB
72
CALL
Fifth Third Bancorp
FITB
$52B
$2.29M 0.25%
82,200
+61,100
+290% +$1.67M
CBOE icon
73
CALL
Cboe Global Markets
CBOE
$29.8B
$2.29M 0.25%
+22,100
New +$2.29M
KEYS icon
74
CALL
Keysight
KEYS
$54.5B
$2.29M 0.25%
25,500
+12,100
+90% +$1.03M
ADM icon
75
CALL
Archer Daniels Midland
ADM
$41.4B
$2.28M 0.25%
55,800
+33,700
+152% +$1.4M

Similar funds

Walleye Capital's Q2 2019 Portfolio in Review

As of Q2 2019, Walleye Capital held 2,256 positions worth $910M, up 50% from $607M the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.

Walleye Capital deployed $298M of net new capital in Q2 2019, opening 789 new positions and adding to 455 existing holdings. Its largest new stake was GX Acquisiton Corp. Unit: 261,600 shares worth $2.63M.

By sector, the portfolio is most concentrated in Healthcare at 1.8% of assets, up from 1.3% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Tortoise Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half, an estimated $1.87M trimmed.

  • Walleye Capital's largest Q2 2019 buy was GX Acquisiton Corp. Unit: 261,600 shares worth $2.63M.
  • Walleye Capital added most to Cronos Group in Q2 2019, an estimated $727K increase.
  • Walleye Capital's biggest Q2 2019 reduction was Tortoise Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half, cutting an estimated $1.87M.
  • Walleye Capital fully exited Pivotal Acquisition Corp. in Q2 2019, selling an estimated $1.27M.
  • Walleye Capital's ten largest holdings make up 6.3% of its $910M portfolio in Q2 2019.
  • Walleye Capital opened 789 new positions and closed 581 in Q2 2019.
  • Walleye Capital's portfolio value rose 50% quarter-over-quarter to $910M.

Based on Walleye Capital's 13F filing for Q2 2019, filed 14 Aug 2019.